3106 Open label, multicenter, prospective non-interventional study to monitor the safety and effectiveness of Bevacizumab with chemotherapy in patients with NSCLC under conditions of routine clinical practice in Germany. (September 2015) - Tessen, H.W.; Linck, D.; Losem, C.; Gessner, C.; Metze, H.